Congresses and Events

New EWOLUTION two-year results confirm that WATCHMAN™ is safe and effective in stroke risk reduction

The EWOLUTION 2 years data presented at EHRA 2018 congress, confirm that WATCHMAN is safe and effective in stroke risk reduction. EWOLUTION, the largest prospective real-life study on WATCHMAN, showed a high success of implant and sealing, with low procedural adverse event rates.1

Use of the GUIDEZILLA™ II Guide Extension Catheter in Order to Deliver Stents in Tortuous and Calcified Distal Lesions



Dr. Tim G. Schäufele
Robert-Bosch-Krankenhaus Stuttgart, Germany

The percentage of complex procedures has increased significantly over the last years, bringing along the need to use the best tools to manage complications. GUIDEZILLA™ II is a new Guide Extension Catheter which provides additional back-up support and facilitates easy delivery of ancillary devices. Learn more about Dr. Schäufele’s experience in using GUIDEZILLA II through complex anatomies.

Dr. Ferenc is using SAMURAI™ Workhorse Wire for its trackability and pushability in complex lesions

Learn more about Dr M. Ferenc’s experience in using SAMURAI Workhorse Wires, which are part of the SENTAI family, a high-performance line of Japanese-enginereed guidewires.
SAMURAI’s innovative design provides exceptional torque performance, trackability and pushability in tortuous anatomy. 

References

1. Boersma LV et al. Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year followup outcome data of the EWOLUTION trial. Heart Rhythm. 2017 Sep;14(9):1302-1308.

Top